Paul Bauer - Selective Insurance Independent Director
| SIGI Stock | USD 94.00 8.28 8.10% |
Director
Mr. Paul D. Bauer is Independent Director of Selective Insurance Group, Inc. Mr. Bauer is the former chief financial officer of a publiclytraded company and served as the Chairman of Selectives Audit Committee for eight years since 2017.
| Age | 73 |
| Tenure | 7 years |
| Address | 40 Wantage Avenue, Branchville, NJ, United States, 07890 |
| Phone | 973 948 3000 |
| Web | https://www.selective.com |
Selective Insurance Management Efficiency
The company has return on total asset (ROA) of 0.027 % which means that it generated a profit of $0.027 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1333 %, meaning that it created $0.1333 on every $100 dollars invested by stockholders. Selective Insurance's management efficiency ratios could be used to measure how well Selective Insurance manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0. As of now, Selective Insurance's Debt To Assets are decreasing as compared to previous years. The Selective Insurance's current Fixed Asset Turnover is estimated to increase to 53.37, while Non Current Assets Total are projected to decrease to under 10.6 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mary Coe | Merck Company | 54 | |
| William Harrison | Merck Company | 70 | |
| Craig Thompson | Merck Company | 64 | |
| Paul Rothman | Merck Company | 63 | |
| Wendell Weeks | Merck Company | 59 | |
| Christine Seidman | Merck Company | 68 | |
| Patricia Russo | Merck Company | 68 | |
| Inge Thulin | Merck Company | 67 | |
| Carlos Represas | Merck Company | 72 | |
| Rochelle Lazarus | Merck Company | 71 | |
| Pamela Craig | Merck Company | 64 | |
| Thomas Cech | Merck Company | 72 | |
| Leslie Brun | Merck Company | 68 | |
| Robert Kidder | Merck Company | 71 | |
| John Noseworthy | Merck Company | 66 | |
| Peter Wendell | Merck Company | 70 | |
| Kathy Warden | Merck Company | 49 | |
| Thomas Glocer | Merck Company | 61 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.027 |
Selective Insurance Leadership Team
Elected by the shareholders, the Selective Insurance's board of directors comprises two types of representatives: Selective Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Selective. The board's role is to monitor Selective Insurance's management team and ensure that shareholders' interests are well served. Selective Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Selective Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Bresney, Executive Officer | ||
| Brad Wilson, Senior Treasurer | ||
| Dale Thatcher, CFO, Principal Accounting Officer and Executive VP | ||
| John Burville, Independent Director | ||
| Elizabeth Mitchell, Independent Director | ||
| Joseph CFA, Executive Officer | ||
| Mark Wilcox, CFO, Executive Vice President | ||
| Philip Urban, Independent Director | ||
| Rohan Pai, VP Treasurer | ||
| Jeffrey Kamrowski, Executive MUSIC | ||
| David Brown, Independent Director | ||
| John Scheid, Independent Director | ||
| Ronald OKelley, Independent Director | ||
| Brian Thebault, Independent Director | ||
| John Marchioni, President COO | ||
| William Rue, Non-Independent Director | ||
| Terrence Cavanaugh, Independent Director | ||
| Gregory Murphy, Chairman, CEO and Chairman of Executive Committee | ||
| Brenda Hall, Executive Lines | ||
| Rohit Mull, Chief VP | ||
| Thomas McCarthy, Director | ||
| Douglas Eden, Executive Vice President Head of Commercial Lines | ||
| Anthony Harnett, VP Officer | ||
| Michael Morrissey, Independent Director | ||
| Vincent Senia, Executive Actuary | ||
| Michael Lanza, Chief Compliance Officer, Executive VP and General Counsel | ||
| Jennifer DiBerardino, Sr. Vice President Investor Relations & Treasurer | ||
| Kimberly Burnett, Chief Human Resources Officer, Executive Vice President | ||
| Lucinda Bennett, Executive Officer | ||
| Cynthia Nicholson, Independent Director | ||
| George Dufala, Executive Vice President - Insurance Operations | ||
| Robert Doherty, Independent Director | ||
| Paul Bauer, Independent Director | ||
| John CPCU, President CEO |
Selective Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Selective Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.027 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 6.6 B | |||
| Shares Outstanding | 60.79 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 84.80 % | |||
| Number Of Shares Shorted | 1.14 M | |||
| Price To Earning | 17.00 X |
Currently Active Assets on Macroaxis
When determining whether Selective Insurance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Selective Insurance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Selective Insurance Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Selective Insurance Group Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Selective Insurance Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Selective Insurance information on this page should be used as a complementary analysis to other Selective Insurance's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Selective Stock analysis
When running Selective Insurance's price analysis, check to measure Selective Insurance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Selective Insurance is operating at the current time. Most of Selective Insurance's value examination focuses on studying past and present price action to predict the probability of Selective Insurance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Selective Insurance's price. Additionally, you may evaluate how the addition of Selective Insurance to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Selective Insurance's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Selective Insurance. If investors know Selective will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Selective Insurance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.455 | Dividend Share 1.25 | Earnings Share 5.84 | Revenue Per Share 69.801 | Quarterly Revenue Growth 0.166 |
The market value of Selective Insurance is measured differently than its book value, which is the value of Selective that is recorded on the company's balance sheet. Investors also form their own opinion of Selective Insurance's value that differs from its market value or its book value, called intrinsic value, which is Selective Insurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Selective Insurance's market value can be influenced by many factors that don't directly affect Selective Insurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Selective Insurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Selective Insurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Selective Insurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.